A Laboratory-based Surveillance Study of Candida Bloodstream Infections (MK-0991-093)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Candidemia

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT01174147

0991-093

Details and patient eligibility

About

This study will evaluate the incidence rate of Candida blood stream infection (candidemia) among people hospitalized in participating medical centers in Brazil, and will assess the antifungal drug susceptibility patterns of Candida clinical isolates. No hypotheses will be tested in the study. Candida blood stream isolates collected from people hospitalized for any reason during the study period will be sent to a core mycology laboratory for antifungal drug susceptibility testing. All people who develop candidemia while hospitalized will be considered participants in the study.

Enrollment: 436 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Hospitalized in a participating medical center
• Developed candidemia blood stream infection (confirmed by isolation of Candida species from blood culture)

Trial design

436 participants in 1 patient group

Hospital Candida Cases

Description:

People who developed a positive blood culture for Candida while hospitalized